OARSI FDA OA Initiative
OARSI FDA Initiative: Public Meeting
Report of the Working Group
on Defining the Disease State
Claim of Symptomatic Relief
Working Group
Safety Working Group
Assessment of Structural
Change
Prevention & Risk Reduction
Working Group
Biomarkers Working Group Members
FDA OARSI Device Committee